Ishita Drugs & Industries share news and announcements

BSE: 524400Pharmaceuticals & BiotechnologySmall Cap

₹70.01₹2.74 (3.77%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹72.75.

52-week range of traded prices to 23 Oct 2026

₹66.00Low, 13 Jan 2026₹90.85High, 29 Dec 2025

Market cap: ₹21 Cr4,064th largest listed
P/E: 29.6
P/B: 1.8
Dividend yield: Nonein the last 12 months
ROE: 6.3%
ROCE: 5.3%
Debt to equity: 0.01
Volume, BSE: 211

Ishita Drugs & Industries share news and announcements

525 announcements, routine notices left out, newest first. Page 2 of 11.

Oct 2025
- 1 Oct · Meeting
  Disclosure of Voting Results and Scrutinizer's Report for 32nd Annual General Meeting of the Company held on Monday, 29th September, 2025 (opens in a new tab)
Sep 2025
Aug 2025
- 30 Aug · INTIMATION OF E- VOTING AS PER THE REGULATION 44 OF SEBI (LODR) REGULATION, 2015
  E voting period for ensuing 32nd AGM which is to be held on 29th September, 2025 will commence from 26th September, 2025 (09:00 IST) and ends on 28th September, 2025 (05:00 IST) (both .... (opens in a new tab)
- 30 Aug · Meeting
  We wish to inform you that Register of members and share transfer book of the Company remain closed from 23rd September, 2025 to 29th September, 2025 (both days Inclusive) for the purpose .... (opens in a new tab)
- 28 Aug · Business
  Disclosure under Regulation 29(2) of SEBI(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from Jagdish Agrawal (opens in a new tab)
- 28 Aug · Business
  Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from Jagdish Agrawal (opens in a new tab)
- 12 Aug · Management
  Board of Directors have approved the re-appointment of Mr. Arvind Vilasrao Sapkal (DIN: 08607096) as a non executive independent director for a second term of Five consecutive years, subject .... (opens in a new tab)
- 12 Aug · Results
  Unaudited Financial Results of the company for the quarter ended 30th june, 2025 along with limited review report issued by the statutory auditor of the Company. (opens in a new tab)
- 12 Aug · Results
  Board of Directors of Ishita Drugs and Industries Limited, at its meeting held today i.e. Tuesday, 12th August, 2025 have 1. Approved the Unaudited Financial Results of the Company .... (opens in a new tab)
- 6 Aug · Board meeting
  Meeting on 12 Aug 2025: quarterly results
- 6 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve 1. To consider, approve .... (opens in a new tab)
Jun 2025
- 25 Jun · Business
  Disclosure Under Regulation 29(2) of SEBI(Substantial Aaquisition of Shares And Takeovers) Regulations, 2011 received from Jagdish Agrawal (opens in a new tab)
- 13 Jun · Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 - Update On Current Business Operations Of The Company
  Update on current business operations of the Company. (opens in a new tab)
- 13 Jun · Results
  Update on current business operations of the Company (opens in a new tab)
- 10 Jun · Board meeting
  Meeting on 13 Jun 2025
- 10 Jun · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 13/06/2025 ,inter alia, to consider and approve 1. To Update regarding .... (opens in a new tab)
May 2025
- 30 May · Management
  Intimation for Appointment of Secretarial Auditor. (opens in a new tab)
- 30 May · Board meeting
  Audited Financial Results for the quarter and year ended on 31st March, 2025. (opens in a new tab)
- 30 May · Board meeting
  Outcome of Board Meeting held on 30th May, 2025 (opens in a new tab)
- 23 May · Board meeting
  Meeting on 30 May 2025: audited results
- 23 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. The Audited Financial .... (opens in a new tab)
- 14 May · Non Applicability Of Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  Non applicability of Regulation 32(1) of SEBI (LODR) Regulation, 2015 for the year ended 31st March, 2025. (opens in a new tab)
Apr 2025
- 14 Apr · Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2025
  Compliance Certificate received from Practicing Company Secretary for the year ended 31st March, 2025. (opens in a new tab)
Mar 2025
- 1 Mar · Business
  Disclosure under regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from Jagdish Agrawal (opens in a new tab)
Feb 2025
- 13 Feb · Results
  Integrated Filing (Financials) for the quarter and nine months ended 31st December, 2024. (opens in a new tab)
- 13 Feb · Results
  Approval of the Unaudited Financial Results of the Company for the quarter ended 31st December, 2024, the limited review report issued by statutory auditor of the company attached herewith. (opens in a new tab)
- 13 Feb · Results
  Board of Directors of Ishita Drugs and Industries Limited, at its meeting held today i.e.13th February, 2025 have 1. Approved the Unaudited Financial Results of the Company for the quarter .... (opens in a new tab)
- 6 Feb · Board meeting
  Meeting on 13 Feb 2025: quarterly results
- 6 Feb · Board meeting
  ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve 1. To consider, .... (opens in a new tab)
Dec 2024
Nov 2024
Oct 2024
Sep 2024
- 30 Sep · Meeting
  Proceedings of 31st Annual General Meeting of the Company held on Monday, 30th September, 2024 at 11:30 A.M. and Concluded on 12:45 P.M. (opens in a new tab)
- 2 Sep · Meeting
  This is to inform you that the 31st Annual General Meeting (AGM) of the Company will be held on Monday, 30th September, 2024 and E voting period for AGM commences on Friday, 27/09/2024 .... (opens in a new tab)
Aug 2024
- 24 Aug · INTIMATION OF E- VOTING AS PER THE REGULATION 44 OF SEBI (LODR) REGULATION, 2015
  E voting period for ensuing 31st AGM which is to be held on 30th September, 2024 will commence from Friday, 27th September, 2024 (09:00 a.m. IST) and ends on Sunday, 29th September, .... (opens in a new tab)
- 24 Aug · Meeting
  We wish to inform you that Register of Members and share transfer book of the Company remain closed from 24th September, 2024 to 30th September, 2024 (both days inclusive) for the purpose .... (opens in a new tab)
- 13 Aug · Management
  1. Board of Directors of our company approved the appointment of Ms. Dhwani Solanki (DIN: 10299290) as as Additional director in the category of non executive independent director for 5 .... (opens in a new tab)